Fulcrum Therapeutics prices $175 million public offering at $13.50 per share Dec 10, 2025 07:48AM
Fulcrum Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering of Common Stock and Pre-Funded Warrants Dec 10, 2025 07:48AM
Fulcrum Therapeutics launches $150 million stock offering Dec 8, 2025 04:01PM
Fulcrum Therapeutics Announces Proposed $150.0 Million Public Offering of Common Stock Dec 8, 2025 04:01PM
Cantor Fitzgerald Reiterates Overweight Rating on Fulcrum Therapeutics (FULC) Oct 3, 2025 07:47AM


Aug 26, 2025 08:00AM Fulcrum Therapeutics to Present at Upcoming Investor Meetings
Jun 20, 2025 06:58AM Cantor Fitzgerald Reiterates Overweight Rating on Fulcrum Therapeutics (FULC)
May 20, 2024 06:33AM Cantor Fitzgerald Starts Fulcrum Therapeutics (FULC) at Overweight
Sep 22, 2023 08:00AM Fulcrum Therapeutics to Participate at the Cantor Fitzgerald Global Healthcare Conference
Sep 8, 2020 07:00AM Fulcrum Therapeutics to Participate in Upcoming Investor Conferences
Sep 8, 2020 07:00AM Fulcrum Therapeutics to Participate in Upcoming Investor Conferences